Research will be conducted with human volunteers to examine the reinforcing, behavioral, and subjective effects of benzodiazepines and anorectic stimulants. Five interrelated sets of experiments on benzodiazepines will be undertaken on a residential research ward with volunteers with histories of drug abuse. One set of experiments will explore differences in reinforcing properties and abuse liability by systematically comparing compounds to interest. The second set of studies will characterize the interactive effects between diazepam and methadone. Another set of experiments will examine the effects of a benzodiazepine receptor antagonist alone, and in combination with several psychoactive drugs including diazepam. The fourth set of studies will characterize benzodiazepine interactions with caffeine administration and coffee drinking. The final set of studies will be undertaken to develop and refine a variety of behavioral measures which may be sensitive to benzodiazepines. Concurrent with conducting these experiments on the residential unit, a series of studies will be undertaken to examine the reinforcing, behavioral, and subjective effects of anorectic stimulant drugs in the context of a therapeutic outpatient treatment program for overweight. As a whole, the experiments will provide information about the relative abuse liability of benzodiazepines and anorectic stimulants. In addition, studies of benzodiazepines will provide information about the basic pharmacological and molecular mechanisms of action of these widely used therapeutic agents. More generally, this research project will contribute to an improved understanding of benzodiazepine and anorectic stimulant drug abuse, and will ultimately contribute to the development of improved prevention, control, and treatment procedures.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA003889-08
Application #
3208673
Study Section
Special Emphasis Panel (SRCD (06))
Project Start
1984-07-01
Project End
1992-06-14
Budget Start
1991-06-01
Budget End
1992-06-14
Support Year
8
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Barrett, Frederick S; Carbonaro, Theresa M; Hurwitz, Ethan et al. (2018) Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition. Psychopharmacology (Berl) 235:2915-2927
Foncelle, Alexandre; Mendes, Alexandre; J?drzejewska-Szmek, Joanna et al. (2018) Modulation of Spike-Timing Dependent Plasticity: Towards the Inclusion of a Third Factor in Computational Models. Front Comput Neurosci 12:49
Carbonaro, Theresa M; Johnson, Matthew W; Hurwitz, Ethan et al. (2018) Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences. Psychopharmacology (Berl) 235:521-534
Griffiths, Roland R; Johnson, Matthew W; Richards, William A et al. (2018) Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. J Psychopharmacol 32:49-69
J?drzejewski-Szmek, Zbigniew; Abrahao, Karina P; J?drzejewska-Szmek, Joanna et al. (2018) Parameter Optimization Using Covariance Matrix Adaptation-Evolutionary Strategy (CMA-ES), an Approach to Investigate Differences in Channel Properties Between Neuron Subtypes. Front Neuroinform 12:47
Barrett, Frederick S; Griffiths, Roland R (2018) Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates. Curr Top Behav Neurosci 36:393-430
Johnson, Matthew W; Garcia-Romeu, Albert; Griffiths, Roland R (2017) Long-term follow-up of psilocybin-facilitated smoking cessation. Am J Drug Alcohol Abuse 43:55-60
Barrett, Frederick S; Robbins, Hollis; Smooke, David et al. (2017) Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions. Front Psychol 8:1238
Johnson, Matthew W; Griffiths, Roland R (2017) Potential Therapeutic Effects of Psilocybin. Neurotherapeutics 14:734-740
Johnson, Matthew W; Garcia-Romeu, Albert; Johnson, Patrick S et al. (2017) An online survey of tobacco smoking cessation associated with naturalistic psychedelic use. J Psychopharmacol 31:841-850

Showing the most recent 10 out of 110 publications